Quick Dispatch:
Your glp-1 and prostate cancer Targeting obesity, metabolic syndrome, and prostate cancer: GLP-1 agonists as emerging therapeutic agents | Discover Oncology orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your glp-1 and prostate cancer Targeting obesity, metabolic syndrome, and prostate cancer: GLP-1 agonists as emerging therapeutic agents | Discover Oncology ships.
Need Help?
Questions about glp-1 and prostate cancer Targeting obesity, metabolic syndrome, and prostate cancer: GLP-1 agonists as emerging therapeutic agents | Discover Oncology, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for glp-1 and prostate cancer Targeting obesity, metabolic syndrome, and prostate cancer: GLP-1 agonists as emerging therapeutic agents | Discover Oncology in your area.
Potential preventive properties of GLP-1 receptor agonists against prostate cancer: a nationwide cohort study | Diabetologia
29.21
GLP-1 Receptor Agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways
27.84
Frontiers
25.13
Depicts Mechanisms of Prostate Cancer Prevention by GLP-1RAs. GLP-1RA:
24.98
Forced expression of glucagon‐like peptide‐1 receptor (GLP‐1R)
22.75
Glucagon-like peptide-1 medicines and cancer
21.11
The GLP-1 receptor is expressed in vivo by human metastatic prostate cancer in: Endocrine Oncology Volume 4 Issue 1 (2024)
20.17
